Introducing EMJ Nephrology 5.1

Introducing EMJ Nephrology 5.1

Nephrology July 18, 2017 at 9:05 AM 0 comments

United Kingdom, July 18, 2017: Welcome to the latest edition of EMJ Nephrology. This instalment presents a complete review of the incredibly successful ERA-EDTA Congress 2017, which this year was held in Madrid, Spain. Speakers from >100 countries were in attendance to share their knowledge in the form of lectures,Read More

RedHill Biopharma Announces Expected Timeline for DSMB Meeting and Provides Update on Enrollment in the RHB-104 Phase III Study for Crohn’s Disease

Uncategorized July 12, 2017 at 4:58 PM 0 comments

The second independent Data and Safety Monitoring Board (DSMB) meeting of the RHB-104 Phase III study for Crohn’s disease (MAP US study) is planned to be held in late July 2017 and will assess the safety and efficacy of RHB-104 in the first 222 subjects who have completed week 26Read More

Abu Dhabi Health Show Comes to London

Uncategorized July 12, 2017 at 4:53 PM 0 comments

London, UK, 12 July, 2017 – Pri-Med Global is to re-brand its healthcare event into Future Healthcare UK, international exhibition and conference. The initial show was launched in May 2017 and leveraged partnerships with many influential organisations, both in the UK and around the world. An unprecedented response to the launchRead More

Updated St. Gallen International Breast Cancer Guidelines Reinforce Important Role of Genomic Testing in Treatment of Early Breast Cancer

Oncology July 12, 2017 at 11:59 AM 0 comments

Oncotype DX® test endorsed for guiding treatment decisions on adjuvant chemotherapy both in node-negative and in node-positive disease Gene expression signatures recommended for the first time as preferable to standard pathology, when adequate reproducibility is not granted Geneva, Switzerland, 12 July, 2017 – Genomic Health today announced that the 15thRead More

Agendia’s MammaPrint® Recommended by ASCO Breast Cancer Guideline in Focused Update Based on Landmark MINDACT Trial Data

Oncology July 11, 2017 at 4:39 PM 0 comments

ASCO recommends MammaPrint® for clinical high risk, hormone receptor-positive, HER2-negative breast cancer, to inform decisions on withholding chemotherapy ASCO recommends MammaPrint as currently the only genomic test to be used to guide treatment decisions for 1-3 lymph node positive early-stage breast cancer patients Revised ASCO Guidelines mark the fourth positiveRead More

Latest Business Conditions Survey Manufacturing Costs and a Challenging NHS Concern UK MedTech

Uncategorized July 7, 2017 at 12:02 AM 0 comments

07 July, 2017 – Accessing the NHS and the impact of the weak pound top the list of concerns for Britain’s Medical Technology (MedTech) industry, one year on from the EU referendum. The latest business conditions survey of the Association of British Healthcare Industries (ABHI) members shows that: 70% ofRead More

Introducing EMJ Interventional Cardiology 5.1

Introducing EMJ Interventional Cardiology 5.1

Interventional Cardiology July 4, 2017 at 9:18 AM 0 comments

United Kingdom, July 04, 2017: Welcome to the latest edition of EMJ Interventional Cardiology. This instalment is bursting with the latest news from the world of interventional cardiology, including interviews with leaders in the field, abstracts, and peer-reviewed articles. The height of summer coincides with a plethora of European congressRead More

Philips Unveils IntelliVue X3 in Europe for Continuous Critical Care Patient Monitoring During In-Hospital Transport

Innovations June 28, 2017 at 11:35 AM 0 comments

New technology integrates seamlessly into IntelliVue Patient Monitoring system to deliver real-time data records and enhance clinical decision support. Amsterdam, The Netherlands, 26 June, 2017 – Royal Philips (NYSE: PHG AEX: PHIA), a global health technology company, today announced the release of the IntelliVue X3 in Europe. Designed for portable, uninterruptedRead More

Abbott Introduces the Alinity hq Hematology Analyzer, the Newest Addition to the Alinity Family of Harmonized Systems

Hematology June 15, 2017 at 11:28 AM 0 comments

The Alinity hq next generation system is designed to streamline workflow and transform operational performance to help laboratories and hospital systems achieve measurably better healthcare performance. Maidenhead, UK, 15 June, 2017 – Abbott announced today that the Alinity hq analyzer for hematology is now CE Marked and available in Europe andRead More

Abbott Broadens Product Offering in Coagulation with Expanded Launch of the Sekisui CP3000 Fully Automated Coagulation System

Hematology June 15, 2017 at 11:23 AM 0 comments

Coagulation tests measure a person’s blood clotting ability, which can help clinicians assess risks of excessive bleeding or clotting. The CP3000 coagulation system can optimize laboratory workflow and expedite the time to produce accurate test results. The system’s compact design and high-throughput testing capabilities make it one of the most efficient coagulation systemsRead More